“I think it is pretty easy to see why we are thrilled at our prospects with four different mid-stage trials ongoing,” said Arthur P. Bertolino, MD, PhD, MBA, President and Chief Medical Officer at Cellceutix. “Each study has a valuable component in demonstrating the robustness and potential of our pipeline and I greatly look forward to what I suspect will be a 2017 with a steady flow of information across all four trials.”
P 2b DONE this year
OM Done this year
UP Done this year
K-O Done this year
At LEAST 2 HUGE partnerships. 5-10 Billion MC.
You do the math.